1-3 of 3
Tricia L Peters, MD, MS
Close
Save search
Sort by
Journal Articles

Plasma Biomarker Profiling In Langerhans Cell Histiocytosis: Risk-Stratifying The Inflammatory Storm

Free
Miguel Dario Cantu, Tricia L Peters, MD, MS, Karen Phaik-Har Lim, MS, Albert Shih, Rikhia Chakraborty, PhD, Harshal Abhyankar, MS, Maria Angelica Cantu, MD, Kenneth McClain, MD, PhD, Tsz-Kwong Chris Man, PhD, Carl E. Allen, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2854.
https://doi.org/10.1182/blood.V122.21.2854.2854
Published: 2013
Journal Articles

Hematopoietic Stem Cells and Circulating Myelomonocytic Precursors With BRAF-V600E Are Identified In High-Risk Patients and Define LCH As a Myeloid Neoplasia

Free
Karen Phaik-Har Lim, MS, Tricia L Peters, MD, MS, Marie-Luise Berres, MD, Jeremy Price, Hitoshi Takizawa, PhD, Philip Lupo, PhD, M. John Hicks, MD, PhD, DDS, Albert Shih, Stephen James Simko, III, MD, Kenneth Matthew Heym, MD, Venetia Bigley, MD, PhD, Matthew P. Collin, MD, PhD, Markus G. Manz, MD, Kenneth McClain, MD, PhD, Miriam Merad, MD, PhD, Carl E. Allen, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 103.
https://doi.org/10.1182/blood.V122.21.103.103
Published: 2013
Journal Articles

Frequent BRAF V600E Mutations Are Identified in CD207+ Cells in LCH Lesions, but BRAF Status does not Correlate with Clinical Presentation of Patients or Transcriptional Profiles of CD207+ Cells

Free
Tricia L Peters, MD, MS, Tsz-Kwong Chris Man, PhD, Jeremy Price, Renelle George, Phaik Har Lim, MS, Kenneth Matthew Heym, MD, Miriam Merad, MD, PhD, Kenneth L. McClain, MD, PhD, Carl E Allen, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1372.
https://doi.org/10.1182/blood.V118.21.1372.1372
Published: 2011